Preventive and therapeutic effects of Lactobacillus Paracasei B21060-based synbiotic treatment on gut inflammation and barrier integrity in colitic mice

Journal of Nutrition

Volumn 145, Issue 6, 2015, Pages 1202-1210

  Simeoli, Raffaele ^a,b   Raso, Giuseppina Mattace ^a   Lama, Adriano ^a   Pirozzi, Claudio ^a   Santoro, Anna ^a   Di Guida, Francesca ^a   Sanges, Marco ^a   Aksoy, Ezra ^b   Calignano, Antonio ^a   D'Arienzo, Agesilao ^a   Meli, Rosaria ^a  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

B defensin 1; DSS colitis; Mucin 1; Neutrophil recruitment; Oxidative nitrosative stress; Probiotic; Tight junction

Indexed keywords

BETA DEFENSIN; DEXTRAN SULFATE; INTERLEUKIN 10; LEUKOCYTE ELASTASE; MALONALDEHYDE; MESSENGER RNA; MUCIN; MYELOPEROXIDASE; OCCLUDIN; PROSTAGLANDIN SYNTHASE; SYNBIOTIC AGENT; TAP WATER; TUMOR NECROSIS FACTOR; CYCLOOXYGENASE 2; DEFB1 PROTEIN, MOUSE; MUC1 PROTEIN, MOUSE; MUCIN 1; PEROXIDASE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PTGS2 PROTEIN, MOUSE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BAGG ALBINO MOUSE; BODY WEIGHT; COLON INJURY; CONTROLLED STUDY; DISEASE ACTIVITY; ENZYME ACTIVITY; EXPERIMENTAL COLITIS; EXPERIMENTAL STUDY; GENE EXPRESSION; GENETIC TRANSCRIPTION; IMMUNOCOMPETENT CELL; LACTOBACILLUS PARACASEI; MALE; MOUSE; MOUSE MODEL; NITROSATIVE STRESS; NONHUMAN; OXIDATIVE STRESS; PERMEABILITY BARRIER; PROTEIN EXPRESSION; THERAPY EFFECT; WEIGHT REDUCTION; ANIMAL; COLITIS; DISEASE MODEL; GASTROINTESTINAL TRACT; GENETICS; INFLAMMATION; LACTOBACILLUS; METABOLISM; MICROBIOLOGY; UPREGULATION;

LACTOBACILLUS PARACASEI; MUS;

ANIMALS; BETA-DEFENSINS; COLITIS; CYCLOOXYGENASE 2; DEXTRAN SULFATE; DISEASE MODELS, ANIMAL; GASTROINTESTINAL TRACT; INFLAMMATION; INTERLEUKIN-10; LACTOBACILLUS; MALE; MALONDIALDEHYDE; MICE; MICE, INBRED BALB C; MUCIN-1; OXIDATIVE STRESS; PEROXIDASE; PPAR GAMMA; RNA, MESSENGER; SYNBIOTICS; UP-REGULATION;

EID: 84930799968     PISSN: 00223166     EISSN: 15416100     Source Type: Journal    
DOI: 10.3945/jn.114.205989     Document Type: Article

References (50)

1. Hooper LV, Wong MH, Thelin A, Hansson L, Falk PG, Gordon JI. Molecular analysis of commensal host-microbial relationships in the intestine. Science 2001;291:881-4.
2. Podolsky DK. Inflammatory bowel disease. N Engl J Med 2002;347:417-29.
3. Johansson ME, Larsson JM, Hansson GC. The two mucus layers of colon are organized by the MUC2 mucin, whereas the outer layer is a legislator of host-microbial interactions. Proc Natl Acad Sci USA 2011;108: Suppl 1:4659-65.
4. Rolhion N, Darfeuille-Michaud A. Adherent-invasive Escherichia coli in inflammatory bowel disease. Inflamm Bowel Dis 2007;13:1277-83.
5. Bartlett JG. Changing trends in bacterial infections: Staphylococcus aureus, bacterial pneumonia, Clostridium difficile. Top HIV Med 2007;15:94-8.
6. Mylonaki M, Rayment NB, Rampton DS, Hudspith BN, Brostoff J. Molecular characterization of rectal mucosa-associated bacterial flora in inflammatory bowel disease. Inflamm Bowel Dis 2005;11:481-7.
7. Giaffer MH, Holdsworth CD, Duerden BI. The assessment of faecal flora in patients with inflammatory bowel disease by a simplified bacteriological technique. J Med Microbiol 1991;35:238-43.
8. Mallon P, McKay D, Kirk S, Gardiner K. Probiotics for induction of remission in ulcerative colitis. Cochrane Database Syst Rev 2007; CD005573.
9. Naidoo K, Gordon M, Fagbemi AO, Thomas AG, Akobeng AK. Probiotics for maintenance of remission in ulcerative colitis. Cochrane Database Syst Rev 2011;CD007443.
10. Gionchetti P, Rizzello F, Campieri M. Probiotics in gastroenterology. Curr Opin Gastroenterol 2002;18:235-9.
11. Macpherson AJ, Uhr T. Induction of protective IgA by intestinal dendritic cells carrying commensal bacteria. Science 2004;303:1662-5.
12. Niess JH, Reinecker HC. Lamina propria dendritic cells in the physiology and pathology of the gastrointestinal tract. Curr Opin Gastroenterol 2005;21:687-91.
13. Rescigno M, Rotta G, Valzasina B, Ricciardi-Castagnoli P. Dendritic cells shuttle microbes across gut epithelial monolayers. Immunobiology 2001;204:572-81.
14. Mileti E, Matteoli G, Iliev ID, Rescigno M. Comparison of the immunomodulatory properties of three probiotic strains of Lactobacilli using complex culture systems: prediction for in vivo efficacy. PLoS ONE 2009;4:e7056.
15. Mattace Raso G, Simeoli R, Iacono A, Santoro A, Amero P, Paciello O, Russo R, D'Agostino G, Di Costanzo M, Canani RB, et al. Effects of a Lactobacillus paracasei B21060 based synbiotic on steatosis, insulin signaling and toll-like receptor expression in rats fed a high-fat diet. J Nutr Biochem 2014;25:81-90.
16. Neuman MG. Immune dysfunction in inflammatory bowel disease. Transl Res 2007;149:173-86.
17. Ludwiczek O, Vannier E, Borggraefe I, Kaser A, Siegmund B, Dinarello CA, Tilg H. Imbalance between interleukin-1 agonists and antagonists:relationship to severity of inflammatory bowel disease. Clin Exp Immunol 2004;138:323-9.
18. Casini-Raggi V, Kam L, Chong YJ, Fiocchi C, Pizarro TT, Cominelli F. Mucosal imbalance of IL-1 and IL-1 receptor antagonist in inflammatory bowel disease. A novel mechanism of chronic intestinal inflammation. J Immunol 1995;154:2434-40.
19. Okayasu I, Hatakeyama S, YamadaM, Ohkusa T, Inagaki Y, Nakaya R. A novel method in the induction of reliable experimental acute and chronic ulcerative colitis in mice. Gastroenterology 1990;98:694-702.
20. Melgar S, Karlsson A, Michaelsson E. Acute colitis induced by dextran sulfate sodium progresses to chronicity in C57BL/6 but not in BALB/c mice: correlation between symptoms and inflammation. Am J Physiol Gastrointest Liver Physiol 2005;288:G1328-38.
21. Dieleman LA, Pena AS, Meuwissen SG, van Rees EP. Role of animal models for the pathogenesis and treatment of inflammatory bowel disease. Scand J Gastroenterol Suppl 1997;223:99-104.
22. Cooper HS, Murthy SN, Shah RS, Sedergran DJ. Clinicopathologic study of dextran sulfate sodium experimental murine colitis. Lab Invest 1993;69:238-49.
23. Mattace Raso G, Simeoli R, Russo R, Santoro A, Pirozzi C, d'Emmanuele di Villa Bianca R, Mitidieri E, Paciello O, Pagano TB, Orefice NS, et al. N-Palmitoylethanolamide protects the kidney from hypertensive injury in spontaneously hypertensive rats via inhibition of oxidative stress. Pharmacol Res 2013;76:67-76.
24. Mullane KM, Westlin W, Kraemer R. Activated neutrophils release mediators that may contribute to myocardial injury and dysfunction associated with ischemia and reperfusion. Ann N Y Acad Sci 1988;524:103-21.
25. Bradley PP, Priebat DA, Christensen RD, Rothstein G. Measurement of cutaneous inflammation: estimation of neutrophil content with an enzyme marker. J Invest Dermatol 1982;78:206-9.
26. Smith JW, Castro GA. Relation of peroxidase activity in gut mucosa to inflammation. Am J Physiol 1978;234:R72-9.
27. Peyrin-Biroulet L, Beisner J, Wang G, Nuding S, Oommen ST, Kelly D, Parmentier-Decrucq E, Dessein R, Merour E, Chavatte P, et al. Peroxisome proliferator-activated receptor gamma activation is required for maintenance of innate antimicrobial immunity in the colon. Proc Natl Acad Sci USA 2010;107:8772-7.
28. Yan Y, Kolachala V, Dalmasso G, Nguyen H, Laroui H, Sitaraman SV, Merlin D. Temporal and spatial analysis of clinical andmolecular parameters in dextran sodium sulfate induced colitis. PLoS ONE 2009;4:e6073.
29. Chassaing B, Aitken JD, Malleshappa M, Vijay-Kumar M. Dextran sulfate sodium (DSS)-induced colitis in mice. Curr Protoc Immunol 2014:15-25.
30. Kawada M, Arihiro A, Mizoguchi E. Insights from advances in research of chemically induced experimental models of human inflammatory bowel disease. World J Gastroenterol 2007;13:5581-93.
31. Morelli L, Zonenschain D, Callegari ML, Grossi E, Maisano F, Fusillo M. Assessment of a new synbiotic preparation in healthy volunteers:survival, persistence of probiotic strains and its effect on the indigenous flora. Nutr J 2003;2:11.
32. Ibnou-Zekri N, Blum S, Schiffrin EJ, von derWeid T. Divergent patterns of colonization and immune response elicited from two intestinal Lactobacillus strains that display similar properties in vitro. Infect Immun 2003;71:428-36.
33. Passariello A, Terrin G, Cecere G, Micillo M, De Marco G, Di Costanzo M, Cosenza L, Leone L, Nocerino R, Canani RB. Randomised clinical trial: efficacy of a new synbiotic formulation containing Lactobacillus paracasei B21060 plus arabinogalactan and xilooligosaccharides in children with acute diarrhoea. Aliment Pharmacol Ther 2012;35:782-8.
34. Brazil JC, Louis NA, Parkos CA. The role of polymorphonuclear leukocyte trafficking in the perpetuation of inflammation during inflammatory bowel disease. Inflamm Bowel Dis 2013;19:1556-65.
35. Mantovani A, Sica A, Sozzani S, Allavena P, Vecchi A, Locati M. The chemokine system in diverse forms of macrophage activation and polarization. Trends Immunol 2004;25:677-86.
36. Nathan C. Neutrophils and immunity: challenges and opportunities. Nat Rev Immunol 2006;6:173-82.
37. Witko-Sarsat V, Rieu P, Descamps-Latscha B, Lesavre P, Halbwachs-Mecarelli L. Neutrophils: molecules, functions and pathophysiological aspects. Lab Invest 2000;80:617-53.
38. Linskens RK, Huijsdens XW, Savelkoul PH, Vandenbroucke-Grauls CM, Meuwissen SG. The bacterial flora in inflammatory bowel disease:current insights in pathogenesis and the influence of antibiotics and probiotics. Scand J Gastroenterol Suppl 2001;234:29-40.
39. Guarner F, Malagelada JR. Gut flora in health and disease. Lancet 2003;361:512-9.
40. Sellon RK, Tonkonogy S, Schultz M, Dieleman LA, Grenther W, Balish E, Rennick DM, Sartor RB. Resident enteric bacteria are necessary for development of spontaneous colitis and immune system activation in interleukin-10-deficient mice. Infect Immun 1998;66:5224-31.
41. Swidsinski A, Ladhoff A, Pernthaler A, Swidsinski S, Loening-Baucke V, Ortner M, Weber J, Hoffmann U, Schreiber S, Dietel M, et al. Mucosal flora in inflammatory bowel disease. Gastroenterology 2002;122:44-54.
42. Ruseler-van Embden JG, Schouten WR, van Lieshout LM. Pouchitis:result of microbial imbalance? Gut 1994;35:658-64.
43. Poritz LS, Garver KI, Green C, Fitzpatrick L, Ruggiero F, Koltun WA. Loss of the tight junction protein ZO-1 in dextran sulfate sodium induced colitis. J Surg Res 2007;140:12-9.
44. McGuckin MA, Eri R, Simms LA, Florin TH, Radford-Smith G. Intestinal barrier dysfunction in inflammatory bowel diseases. Inflamm Bowel Dis 2009;15:100-13.
45. Kim YS, Ho SB. Intestinal goblet cells and mucins in health and disease:recent insights and progress. Curr Gastroenterol Rep 2010;12:319-30.
46. Plaut AG. Trefoil peptides in the defense of the gastrointestinal tract. N Engl J Med 1997;336:506-7.
47. Matsuo K, Ota H, Akamatsu T, Sugiyama A, Katsuyama T. Histochemistry of the surface mucous gel layer of the human colon. Gut 1997;40:782-9.
48. Hoebler C, Gaudier E, De Coppet P, Rival M, Cherbut C. MUC genes are differently expressed during onset and maintenance of inflammation in dextran sodium sulfate-treated mice. Dig Dis Sci 2006;51:381-9.
49. Hirota SA, Ng J, Lueng A, Khajah M, Parhar K, Li Y, Lam V, Potentier MS, Ng K, Bawa M, et al. NLRP3 inflammasome plays a key role in the regulation of intestinal homeostasis. Inflamm Bowel Dis 2011;17:1359-72.
50. Guandalini S. Are probiotics or prebiotics useful in pediatric irritable bowel syndrome or inflammatory bowel disease? Front Med (Lausanne) 2014;1:23.